{"prompt": "['54', '15.1.7: CRF VII; End of Trial', 'Case Record Form VII', '(End of Trial)', 'Study Id: V1_OTH/DR; AMD-I/2022 [Transferred from the system]', 'Participant Id-number:', '[Transferred from CRF I]', 'Please state the trial end reason:', 'Completion of trial', 'Withdrawal: patient withdrew consent.', 'Date withdrawal (dd-mm-yyyy):', 'Reason withdrawal:', 'Adverse experience - please specify:', 'Inter-current illness (must be reported as an AE)', 'Protocol Violation- - please specify:', 'Drop-out: patient request.', 'Date drop-out (dd-mm-yyyy):', 'Patient lost to follow up.', 'Date last contact (dd-mm-yyyy):', 'Death - must be reported as a SAE.', 'Date of death (dd-mm-yyyy):', 'Other, please specify:', 'Date of discontinuation (dd-mm-yyyy):', 'I hereby certify that the entries on all pages of this Case Report Form accurately and', 'completely represent the results of the examinations, tests, and evaluations performed on the', 'dates specified.', 'Date:', \"Investigator's signature:\", 'BulbiCam; Validity study:', 'V1_OTH/DR; AMD-I/2022:', 'Final Version 1.5 22nd March 2022']['55', '15.2: Bulbicam Certificate', '15.2.1: ISO-Certificate', 'SIO', 'Certificat/Certificate', 'for', 'Management System', 'BULBITECH AS', 'Dybdahls veg 5, 7051 Trondheim', 'Research, design and development, production, sales, distribution and servicing', 'of ophthalmic medical devices and software for ophthalmic medical devices', 'List of locations at the addendum to the certificate:', 'BulbiTech AS, Dybdahls veg 5, 7051 Trondheim, Norway', 'HEADS Stockholm AB, Gustavslundsv\u00e4gen 143, 16751 Bromma Stockholm, Sweden', 'adequately operates and mointains a management system', 'which neets the requirements of the standard', 'ISO 13485:2016', 'Certificate No, / Certification date', 'M-139 / 2018-10-30', 'Issue 07/2021-12-07 Valid until: 2024-10-30', 'Director of SiQ', 'Gregur Schoss', 'SIQ Je partner', 'SLOVENSKA', '1', '-', 'IQ', 'Net', '-', 'IAF', 'se EX', 'CS-001', 'SIQ Ljubljana, Masera-Spasiceva ulica 10, 1000 Ljubijana. Slovenija', 'BulbiCam; Validity study:', 'V1_OTH/DR; AMD-I/2022:', 'Final Version 1.5 22nd March 2022']['56', '15.2.2: Certificate of. free Sales', 'Norwegian', 'Medicines Agency', 'To Whom it May Concern', 'NO-20/11005', 'Date: 08.02.2021', 'Certificate of Free Sales', 'The Norwagian Medicines Agency as Competent Authority for medical devices hereby certifies that', 'the products listed below are manufactured by:', 'Bulbitech AS', 'Krambugata 2', '7011 Trondheim', 'Norway', 'We have been notified that the following medical devices are sold as CE-marked products:', 'Cat. Number', 'Product Name', '65177', 'BulbiCAM - Vision physiology / eye movement analysis system', 'The precondition for medical devices to be CE-marked in compliance with directive 90/385/EEC,', 'directive 93/42/EEC or directive 98/79 EC is to meet the essential requirements for safety. A CE-', 'marked medical device may therefore be placed on the market in Norway without any approval from the', 'Medicines Agency and may be exported without any restrictions.', 'This certificate is valid until 08. February 2023', 'Raymond Ludvigsen', 'Serior Adviser', 'Jargen Bryn', 'Consultant', 'may', 'Nerveglan Medicines Agency (Noma)', 'Leifers shoukt be adressed to the Mormagion Medicites Agency', 'Fostbek: 240 Skayen 021a Cslo. Noway', \"s'ela sur\", '28, 0863 Own, Nerway', 'TI +47 22 BS 77.30', '3', '7694 es', 'camaro', 'SWIFT DNBANOKK', 'BulbiCam; Validity study:', 'V1_OTH/DR; AMD-I/2022:', 'Final Version 1.5 22nd March 2022']\n\n###\n\n", "completion": "END"}